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Glossary of acronyms listed in alphabetical order 
BDNF: brain-derived neurotrophic factor  HPA: hypothalamic-pituitary-adrenal axis  
CAM: complementary and alternative medicine  HPT: hypothalamic–pituitary–thyroid 
CBT: cognitive behavioural therapy  M1: motor cortex  
CPAP: continuous positive airway pressure NIBS: non-invasive brain stimulation 
DLPFC: dorsolateral prefrontal cortex  OSA: obstructive sleep apnea 
EEG: electroencephalography  rTMS: repetitive transcranial magnetic stimulation 
EPM: endogenous pain modulation  tDCS: transcranial direct current stimulation 
GABA: γ-aminobutyric acid  
 
1. Introduction  
Sleep disturbances and chronic pain often co-exist, with insomnia and obstructive sleep 
apnea (OSA) being the most commonly diagnosed sleep conditions [88]. Individuals with 
chronic pain present poorer and more disturbed sleep than healthy controls, with reduced sleep 
quality and efficiency, longer sleep onset latency, and increased wake after sleep onset [9]. 
Previous hypotheses have emphasized a bidirectional relationship between sleep and pain, with 
poor sleep increasing pain, and pain disturbing sleep. However, the influence of poor sleep on 
chronic pain has received more robust empirical support [4]. These effects may vary depending 
on pain populations and the presence of other comorbidities. Presented independently or jointly, 
disturbed sleep and chronic pain have a significant impact on patients’ well-being, ability to 
function, and quality of life [1; 35; 58].  
A number of different management strategies are available to improve sleep disturbances or 
chronic pain disorders via disrupting the vicious cycle formed by co-existing sleep and pain 
problems, and promoting a situation in which an improvement in one condition may lead to an 





































































independently, with a failure to take a more holistic approach that is based on symptoms rather 
than on the possible underlying mechanisms. This can increase polypharmacy and its 
associated risks such as increased side-effects and the aggravation of other conditions [61; 
132]. Moreover, the heterogeneity in the clinical presentation of this interaction between sleep 
and pain and the considerable variability in treatment responses among these individuals, may 
suggest the presence of different pathways and pathophysiological subtypes related to insomnia 
and OSA.  
Classifying individuals according to different phenotypes (i.e., observable characteristics, 
traits, or clinical presentations without mechanism implication) and ultimately to endotypes (i.e., 
subtype of a disease condition, implying distinct pathophysiological mechanisms) can help to 
characterize diseases and select more targeted therapeutic approaches, especially in the era of 
precision medicine. Some examples can be observed in the fields of OSA [18; 74], chronic 
rhinosinusitis [19] or asthma [71], where different endotypes have been identified to suggest 
different treatment strategies. The identification and grouping of phenotypic vulnerabilities in 
individuals with sleep and pain problems obtained through clinical and physiological tests may 
help discover disease subtypes or endotypes involving different mechanisms and pathways. It is 
possible that insomnia and OSA present different pathways in their relation to pain. Therefore, 
different genetic/demographic (sex, age, ethnicity related), behavioural (wake, emotional and 
sleep related) and possibly physiological (sleep related) phenotypic characteristics could be 
used to recognize insomnia or OSA among individuals with chronic pain [55; 74; 75; 123] 
(Figure 1). Consequently, different management strategies could be selected to target more 
adequately the underpinning putative mechanisms of this interaction. Although these concepts 
still need to be further investigated, the identification of predominant pathways in each sleep 




































































One barrier to this approach is the fact that the exact mechanisms underlying the 
associations between these sleep disorders and chronic pain have not yet been fully elucidated. 
However, different putative mechanisms have been proposed to mediate the relationship 
between sleep disturbances and chronic pain, with four of them being better supported by 
evidence (Figure 1). One proposed mechanism is endogenous pain modulation (EPM) 
alteration. Research has shown that sleep deprivation, which can occur in both insomnia and 
OSA, can amplify pain signals by altering EPM processes such as decreasing pain inhibition or 
pain habituation, or increasing pain facilitation [38; 122; 124; 126]. Another putative mechanism 
associated with both insomnia and OSA is the dysregulation of the autonomic system. It has 
been shown that sleep deprivation can increase sympathetic drive via the sympathoadrenal 
system and the hypothalamic-pituitary adrenal axis [92], which could contribute to an increase in 
nociceptive signals [11]. At the same time, pain can increase sympathetic cardiovascular 
activation [21; 84] and reduce sleep efficiency, thus causing lighter sleep and more arousals, 
which would increase pain sensitivity and consequently reinforce the vicious cycle between 
sleep disturbances and chronic pain [116]. Mood disorders, such as depression and anxiety, 
and negative affect could also be a possible mechanism. They are more frequently observed in 
insomnia, and could also mediate the relationship between sleep and pain [45; 121; 142]. For 
instance, negative mood/affect may increase physiologic or cognitive arousal while in bed or 
during the day, increasing hypervigilance and attentional-reward biases (e.g., increase the 
tendency to selectively attend to pain), which can consequently disturb sleep and increase pain 
[46; 111]. Moreover, negative mood/affect can dysregulate diurnal patterns, decreasing physical 
and social activities during the day, and increasing time in bed ‘‘resting’’ or engaging in non-
sleep activities [106], thus impairing normal sleep. Mood, sleep disturbances, and pain can 
affect each other, further perpetuating the vicious cycle [106]. Finally, another suggested 
mechanism is the presence of systemic inflammation caused by sleep fragmentation in 




































































 In this topical review we aim to describe and assess management strategies that can 
simultaneously target the interaction between sleep and pain problems through different 
mechanisms or pathways, and propose future directions towards the development of putative 
endotypes. Treatments for OSA such as continuous positive airway pressure (CPAP) and oral 
appliances will not be discussed due to the limited evidence in relation to their use and pain 
improvement, although they can be combined with the options described below. 
2. Pharmacological approaches 
Pharmacotherapy is a common approach to manage chronic pain and sleep conditions such 
as insomnia. Although evidence supporting the use of long-term medication is limited, some 
drugs can aid in the disruption of the vicious cycle between sleep disturbances and chronic pain 
in the short-term. Medications directed to treat pain can indirectly help sleep and vice versa. 
However, those that can target both sleep and pain problems more comprehensively via 
different pathways become highly appealing. For example, antiseizure medications such as 
gabapentinoids (e.g., gabapentin, pregabalin) are widely used to manage neuropathic pain or 
fibromyalgia [25; 47]. By acting at the dorsal root ganglion, the dorsal horn neuron level, and 
perhaps at the supra-spinal neuron level, gabapentinoids most likely produce analgesia by 
inhibiting descending serotonergic facilitation and stimulating noradrenergic descending 
inhibition [70]. Moreover, they have anti-inflammatory properties and can influence the affective 
component of pain, which are possible underlying mechanisms of the interaction between sleep 
and pain problems [53; 128; 143]. At the same time, they have independent effects on sleep, 
not only by enhancing slow-wave sleep, improving sleep stability and decreasing spontaneous 
arousal [81; 119], but also by reducing anxiety [62]. Nonetheless, they can aggravate OSA, 
particularly in males [113]. Therefore, while the use of gabapentinoids can be considered in 
chronic pain individuals with co-existent insomnia due to its impact on EPM, inflammatory, and 




































































topiramate [99; 145; 146], duloxetine [20; 67; 83], cannabinoids [9; 24; 69] and sodium oxybate 
[125] are alternatives, but with less empirical support, to manage both sleep disorders and 
chronic pain. Although trazodone might not have any direct analgesic effect, it can increase 
sleep arousal thresholds and improve mood, being useful in hyperarousal and mood related 
pathways [48; 74; 133]. Importantly, the combination of opioids or gabapentin with 
benzodiazepines should be avoided in individuals with sleep disturbances and OSA due to 
opioid-related breathing risks [113; 137]. More research assessing the effects of the 
aforementioned medications is needed to adequately evaluate their benefits in populations in 
which sleep disturbances and chronic pain co-exist and to assess their efficacy in different 
subgroups.  
3. Non-pharmacological approaches. These include treatments such as cognitive 
behavioural therapy (CBT), physical therapy, complementary and alternative medicine (CAM), 
and non-invasive brain stimulation (NIBS). They present minimal side-effects and can 
complement each other and pharmacological therapies, potentially having a synergic effect. 
However, despite some initial evidence suggesting their possible benefits, most of these 
treatments – with the exception of CBT - lack strong evidence supporting their use in co-existing 
sleep and pain problems. While most of them are considered adjuvant therapies, endotyping 
strategies could maximize their potential effectiveness (Figure 1). 
3.1. Hybrid CBT. CBT is an evidence-based therapy designed to target individuals' 
maladaptive cognitions, emotions, and behaviours [10]. CBT was initially designed to treat 
mental health problems such as anxiety and depression, but it has become an important tool to 
manage other conditions such as insomnia [97] and chronic pain [37]. Indeed, CBT for insomnia 
(CBT-I) is a first line option in the management of insomnia, having minimal side-effects and 
demonstrating maintained improvements [135; 144]. In chronic pain, CBT can reduce emotional 




































































Furthermore, CBT-I, sleep hygiene, and psychoeducation have been shown to be effective in 
improving sleep, pain, and mood symptoms in chronic pain populations with insomnia [129]. In 
this context, a hybrid CBT approach combining CBT-I components with interventions targeting 
the cognitive-behavioural aspects of chronic pain has emerged as a promising intervention to 
better tackle sleep and pain problems [44; 130; 131]. Dissemination of CBT approaches 
(particularly the training of therapists to be highly skilled in the provision of both sleep and pain 
treatment) can be costly [89; 101]. These issues could be mitigated through the use of internet-
based and home-based CBT, which have been implemented with high rates of success and 
acceptability [12; 15; 115; 149]. Hybrid CBT programs include general sleep and pain education, 
sleep restriction therapy, stimulus control for sleep and pain, sleep hygiene instructions, 
cognitive therapy specific to sleep and pain thinking, relaxation/stress management, and 
cognition-targeted exercise therapy [104; 130]. Thus, hybrid CBT can help individuals with 
insomnia and co-existing chronic pain, especially when mood disturbances and hyperarousal 
mechanisms are present, by improving cognitive (e.g., catastrophizing, anticipation), affective, 
perceptive and coping skills associated with both sleep disturbances and chronic pain [16; 22; 
39; 49; 91] (Figure 1).  
3.2. Physical therapy. The benefits of physical activity and exercise in individuals with 
chronic pain are well-documented [32; 51]. It is thought that physical activity/exercise can have 
anti-inflammatory effects, reinforce neuromuscular function, and regulate autonomic function 
through hypothalamic-pituitary-adrenal axis (HPA) activity [54]. In addition to reducing obesity (a 
major risk factor for insomnia, OSA and chronic pain) physical activity/exercise can increase 
EPM analgesia by releasing endogenous opioids associated with transient and sometimes long-
lasting anti-nociception states, decreasing pain intensity and improving physical function [51] 
(Figure 1). Moreover, positive effects on sleep related outcomes have been documented with 




































































derived neurotrophic factor (BDNF), which can cause anxiolytic or antidepressant effects [42; 
110; 136; 147]. However, these effects seem to be modest [41]. Importantly, exercise needs to 
be tailored to each individuals’ preferences, limitations, and pain conditions, as some may 
present sensitivity to physical activity [93]. Furthermore, the effects of exercise therapy on sleep 
in individuals with chronic pain are small [51; 87], possibly requiring more specific sleep-
targeted interventions such as CBT-I.    
3.3. CAM. This term refers to medical products and practices that are not part of 
standard medical care. Several CAM strategies can be useful (especially as adjuvant therapies) 
in sleep disturbances and chronic pain. Mind-body therapies such as meditation, yoga, 
mindfulness, or hypnosis [2; 76] [73; 120; 141], music therapy [14; 68], acupuncture [23; 100; 
150], aromatherapy [60; 72], and in a reduced way supplementation with magnesium, 
melatonin, or vitamin D [29; 30; 39; 55; 56; 68; 150] have been associated with certain 
improvements in sleep quality and chronic pain and have the potential to affect different 
pathways (Figure 1). However, evidence supporting their use in the multimorbidity formed by 
sleep disturbances and chronic pain is limited in general, and more high-quality research is 
needed to evaluate their potential properly.  
3.4. NIBS. Repetitive transcranial magnetic stimulation (rTMS) and transcranial direct 
current stimulation (tDCS) are safe NIBS techniques that can increase/decrease cortical 
function and “activate” or “inhibit” different brain networks. rTMS can depolarize neurons 
through magnetic fields, being mostly known for refractory depression management. However, 
rTMS is also effective in improving chronic pain outcomes [59; 77; 107]. rTMS analgesic effects 
are mainly obtained when the motor cortex (M1) is stimulated with high frequencies, by 
activating thalamocortical pathways and brain areas involved in pain processing such as the 
insula, anterior, and cingulate cortices; the putamen; the periaqueductal gray matter [34]; and 




































































been associated with enhanced sleep quality [103; 112], possibly secondarily to pain 
improvement, but perhaps due to stimulation of distant sleep involved networks [56]. However, it 
appears that targeting the left dorsolateral prefrontal cortex (LDLPC) with low frequencies is 
more appropriate in the management of insomnia, as it can balance autonomic function via 
downregulation of the HPA and hypothalamic–pituitary–thyroid (HPT) axes, reduce cortical 
arousal levels [26; 103] and induce the release of melatonin, BDNF and GABA, which are 
important neurotransmitters involved in sleep [43; 63; 127] and analgesia [31; 40; 65]. 
Moreover, research has shown that high frequency stimulation protocols targeting the DLPC 
can increase serotonin and dopamine release, potentially restoring defective brain networks 
present in individuals with sleep deprivation [139], chronic pain [82] and depression [27]. 
Therefore, dual rTMS stimulation of the M1 and LDLPC could potentially target the 
multimorbidity formed by sleep and pain problems from different angles by regulating 
sympathetic function, improving mood, and increasing pain inhibition (Figure 1). Additionally, 
rTMS also showed to improve airflow dynamics in OSA individuals through the stimulation of 
airway dilator muscles during sleep. However, evidence is still initial [57; 102].  
tDCS is another NIBS technique based on electrical currents that can decrease chronic 
pain with anodal protocols over the M1, although with less robust evidence [59; 78; 107]. tDCS 
stimulation of the M1 can increase excitatory postsynaptic potential (129), reverse abnormalities 
in brain activity and physiology, and possibly enhance endogenous pain modulation networks 
(30). Moreover, tDCS may improve pain system function through direct effects on the motor, 
somatosensory, and frontal cortices associated with pain sensitivity [3; 78]. In addition, 
stimulation of the M1 and DLPFC with tDCS can modify electroencephalographic (EEG) 
measures, potentially affecting vigilance and promoting sleepiness by enhancing theta and 
alpha activity during the wake or slow-wave sleep activity [6; 36]. Moreover, it seems that tDCS 




































































sleep-dependent memory consolidation [85; 86]. While there is some evidence showing benefits 
in respect of both sleep and pain when the M1 is stimulated in chronic pain conditions [3; 66; 
118], without appropriately designed studies and mediation analyses it is difficult to determine 
whether the improvements are the direct result of the stimulation or are secondary to the 
improvement of pain [56]. 
Other NIBS techniques with possible potential are transcranial alternating current 
stimulation [7; 140], transcranial random noise stimulation [29; 50; 108], and acoustic slow wave 
enhancement with pink noise [33; 109], although evidence supporting their use is still scarce or 
non-existent in individuals with comorbid sleep and pain problems.  
In short, although evidence for using NIBS (specially rTMS) in individuals suffering from 
sleep and pain problems is growing, more research is required before their use can be 
recommended. 
5. Future directions.  
While there is a significant amount of literature on both sleep disorders and chronic pain 
separately, there is a need for more observational and experimental studies focused on 
populations where both co-exist to better understand this complex relationship. Studies 
designed to identify clusters of individuals according to common phenotypic vulnerabilities or 
clinical characteristics and to grasp the dynamic features of this interaction are needed. 
Understanding the pathophysiological mechanisms of this interaction is essential to being able 
to select the best possible treatments, and the development of new ones. Machine learning 
methods and artificial intelligence algorithms will play a critical role in phenotyping and 
endotyping this multimorbidity and help to close gaps in current knowledge [52] (Figure 2) using 
big data collected from a variety of sources including : a) polysomnography to derive 




































































spindles) indexes [5; 17; 80]; b) autonomic function tests such as cardiovascular reflexes, heart 
rate variability, catecholamine measurements or sudomotor function during sleep or wake [90; 
117]; c) cortical excitability measurements using TMS or electrophysiological methods [138]; d) 
EPM and somatosensory function testing such as conditioned pain modulation, temporal 
summation, offset analgesia, and quantitative sensory testing [8; 28; 79; 94; 95; 148]; and e) 
brain imaging characteristics and networks (functional magnetic resonance imaging) [30], can 
help us to identify clusters and phenotype individuals suffering from sleep and pain disorders 
more precisely and develop “signatures” to recognize endotypes. The investigation of treatment 
response predictors/determinants to NIBS [105; 151] and non-specific effects, can assist in 
tailoring even more precise treatment strategies to treat individuals according to their specific 
needs. Likewise, the exciting field of epigenetics allows the monitoring of possible treatment 





































































Figure 1. Phenotypic vulnerabilities of insomnia and obstructive sleep apnea in chronic pain 
individuals and putative pathways of this relationship to be approached with multitarget 
strategies. 
Legends. Treatment strategies supported by more evidence are represented by thicker 
continuous lines, while the ones with less evidence are thinner and discontinuous. 
Abbreviations: BMI: body mass index; OSA: obstructive sleep apnea; NIBS: non-invasive brain 
stimulation; CBT: cognitive behavioural therapy. 
Figure 2. Conceptual design illustrating how machine learning methods and artificial intelligence 
algorithms can be used to phenotype, endotype, and select treatment avenues in the 
multimorbidity formed by sleep disturbances and chronic pain. 
Legend. Numbers represent machine learning and artificial intelligence methods and do not 
have any other specific connotation.  
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